Report overview
Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.
This report contains market size and forecasts of Nephrology Drugs in Global, including the following market information:
Global Nephrology Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nephrology Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ACE Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nephrology Drugs include AstraZeneca, Pfizer, Amgen, FibroGen, GlaxoSmithkline, AbbVie, Akebia Therapeutics, Teva Pharmaceutical Industries and Johnson & Johnson and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nephrology Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nephrology Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nephrology Drugs Market Segment Percentages, by Type, 2021 (%)
ACE Inhibitors
Calcium Channel Blocker
Beta Blockers
Diuretics
Others
Global Nephrology Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nephrology Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Nephrology Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nephrology Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nephrology Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nephrology Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Pfizer
Amgen
FibroGen
GlaxoSmithkline
AbbVie
Akebia Therapeutics
Teva Pharmaceutical Industries
Johnson & Johnson
Roche
